Karagiannis, George S.
Condeelis, John S.
Oktay, Maja H.
Funding for this research was provided by:
National Institutes of Health (CA100324, CA150344, SIG 1S10OD019961-01)
Gruss-Lipper Biophotonics Center and Integrative Imaging Program
Article History
Received: 13 October 2017
Accepted: 20 December 2017
First Online: 6 January 2018
Compliance with ethical standards
:
: MHO and JSC are inventors on a patent application (#96700/2505) submitted by the Albert Einstein College of Medicine that covers methods detecting and reducing chemotherapy-induced prometastatic changes in breast tumors. GSK declares no competing interests.